azomycin has been researched along with Salivary Gland Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Wilde, PC; Hoogsteen, IJ; Kaanders, JH; Lok, J; Marres, HA; Rijken, PF; van der Kogel, AJ; Wijffels, KI | 1 |
| Munzenrider, JE | 1 |
1 review(s) available for azomycin and Salivary Gland Neoplasms
| Article | Year |
|---|---|
Recent advances in radiotherapy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1977 |
1 other study(ies) available for azomycin and Salivary Gland Neoplasms
| Article | Year |
|---|---|
No detectable hypoxia in malignant salivary gland tumors: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Cell Proliferation; Deoxyuridine; Glucose Transporter Type 1; Glucose Transporter Type 2; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Middle Aged; Nitroimidazoles; Salivary Gland Neoplasms | 2009 |